BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30797969)

  • 1. Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.
    Wang R; Wang Y; Qu L; Chen B; Jiang H; Song N; Xie J
    Neurochem Int; 2019 May; 125():127-135. PubMed ID: 30797969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
    Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
    Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
    Elfarrash S; Jensen NM; Ferreira N; Schmidt SI; Gregersen E; Vestergaard MV; Nabavi S; Meyer M; Jensen PH
    PLoS One; 2021; 16(10):e0252635. PubMed ID: 34613964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo.
    Oueslati A; Schneider BL; Aebischer P; Lashuel HA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3945-54. PubMed ID: 23983262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein.
    Rodríguez-Nogales C; Garbayo E; Martínez-Valbuena I; Sebastián V; Luquin MR; Blanco-Prieto MJ
    Int J Pharm; 2016 Nov; 514(1):142-149. PubMed ID: 27863657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 8. Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants.
    Salvi M; Trashi E; Marin O; Negro A; Sarno S; Pinna LA
    Biochem Biophys Res Commun; 2012 Feb; 418(1):156-60. PubMed ID: 22248692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial ferritin protects SH-SY5Y cells against H
    Guan H; Yang H; Yang M; Yanagisawa D; Bellier JP; Mori M; Takahata S; Nonaka T; Zhao S; Tooyama I
    Exp Neurol; 2017 May; 291():51-61. PubMed ID: 28163159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.
    Inglis KJ; Chereau D; Brigham EF; Chiou SS; Schöbel S; Frigon NL; Yu M; Caccavello RJ; Nelson S; Motter R; Wright S; Chian D; Santiago P; Soriano F; Ramos C; Powell K; Goldstein JM; Babcock M; Yednock T; Bard F; Basi GS; Sham H; Chilcote TJ; McConlogue L; Griswold-Prenner I; Anderson JP
    J Biol Chem; 2009 Jan; 284(5):2598-2602. PubMed ID: 19004816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular α-Synuclein Modulates Iron Metabolism Related Proteins via Endoplasmic Reticulum Stress in MES23.5 Dopaminergic Cells.
    Mi X; Li Q; Wen X; Xie J; Wang Y; Song N
    Neurochem Res; 2021 Jun; 46(6):1502-1513. PubMed ID: 33704649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation.
    Dahmene M; Bérard M; Oueslati A
    J Biol Chem; 2017 Mar; 292(9):3919-3928. PubMed ID: 28154193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin Inhibits Overexpression and Aggregation of α-Synuclein in A53T α-Synuclein Transgenic Mice by Regulating Parkin and PLK2.
    Ma D; Shen C; Zhang X; Zhang L; Li L
    J Integr Neurosci; 2023 Nov; 22(6):166. PubMed ID: 38176950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells.
    Greco M; Spinelli CC; De Riccardis L; Buccolieri A; Di Giulio S; Musarò D; Pagano C; Manno D; Maffia M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress partially contributes to iron-induced α-synuclein aggregation in SK-N-SH cells.
    Li W; Jiang H; Song N; Xie J
    Neurotox Res; 2011 Apr; 19(3):435-42. PubMed ID: 20383623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies.
    Weston LJ; Stackhouse TL; Spinelli KJ; Boutros SW; Rose EP; Osterberg VR; Luk KC; Raber J; Weissman TA; Unni VK
    J Biol Chem; 2021; 296():100273. PubMed ID: 33428941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.
    Ishii A; Nonaka T; Taniguchi S; Saito T; Arai T; Mann D; Iwatsubo T; Hisanaga S; Goedert M; Hasegawa M
    FEBS Lett; 2007 Oct; 581(24):4711-7. PubMed ID: 17868672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-101-3p Contributes to
    Zhang M; Liu W; Zhang Q; Hu H
    J Healthc Eng; 2021; 2021():6147434. PubMed ID: 34234930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death.
    Reimer L; Vesterager LB; Betzer C; Zheng J; Nielsen LD; Kofoed RH; Lassen LB; Bølcho U; Paludan SR; Fog K; Jensen PH
    Neurobiol Dis; 2018 Jul; 115():17-28. PubMed ID: 29501855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of polo like kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei.
    Fitzgerald K; Bergeron M; Willits C; Bowers S; Aubele DL; Goldbach E; Tonn G; Ness D; Olaharski A
    Toxicol Appl Pharmacol; 2013 May; 269(1):1-7. PubMed ID: 23466428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.